EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access

Prescription Drug Promotion by Social Media Influencers

Sascha Gell, Sneha Dave, Erin Willis, Elaina J Vitale, Steven Woloshin, Raffael Heiss

JAMA Network Open · 23.03.2026 · 9 (3) · e262738

DOI: 10.1001/jamanetworkopen.2026.2738 ↗

Kurz gefasst

Scoping Review in der Zeitschrift JAMA Network Open, online erschienen am 23.03.2026. Verfasst von Sascha Gell und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Social and Health Innovation, MCI Management Center Innsbruck, Innsbruck, Austria. Hauptthemen laut MEDLINE: Social Media, Prescription Drugs, Health Promotion. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Prescription drug promotion by social media influencers (hereinafter influencers ) is a growing phenomenon that raises concerns about misleading advice, insufficient regulatory oversight, and ethically problematic marketing practices. Understanding the scope and risks of influencers’ promotional activities is essential to protect public health.

Objective

To systematically review existing research on influencer prescription drug promotion, with a focus on identifying recurring themes, regulatory gaps, and opportunities for intervention. Evidence Review This systematic scoping review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses reporting guideline. The search strategy was developed with a health sciences librarian and preregistered on Open Science Framework. English-language articles from peer-reviewed journals were retrieved from the Medline, Communication & Mass Media Complete, CINAHL Complete, PsycInfo, Web of Science, Business Source Complete, Scopus, and Cochrane Library databases, covering research conducted in diverse online and health care contexts worldwide from 2004 to 2024. Searches used key terms related to influencers, social media, and prescription drugs, completed on March 13, 2024. Included studies underwent thematic analysis. The primary outcomes included concerns related to accuracy (misinformation), transparency (disclosure practices), and persuasiveness (personal and parasocial narratives) of prescription drug promotion by influencers.

Findings

Twelve articles met inclusion criteria (8 empirical and 4 theoretical), addressing topics such as contraceptive advertising, performance-enhancing drugs, and broader pharmaceutical promotion. Methods included content analyses, interviews, and experiments. Three recurring themes emerged: (1) misinformation stemming from influencers’ limited expertise in the context of audiences’ low health literacy; (2) weak regulatory oversight and inconsistent disclosure practices; and (3) parasocial narratives that blur distinctions between personal testimony and paid promotion. Conclusions and Relevance This systematic scoping review study of prescription drug promotion by influencers found that such promotion carried risks of inaccurate or misleading advice, often amplified through personal and emotionally resonant narratives in an environment with limited oversight and enforcement. Despite the small and fragmented evidence base, these findings highlight the urgent need for updated regulatory guidance, standardized and enforceable disclosure requirements, stronger platform accountability, and targeted digital literacy initiatives. Policymakers and researchers should act proactively to safeguard public health.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Social MediaPrescription DrugsHealth PromotionHumansMedia Exposure

Substanzen

Prescription Drugs

Autor:innen und Institutionen

  • Center for Social and Health Innovation, MCI Management Center Innsbruck, Innsbruck, Austria.
  • Department of Communication, University of Vienna, Vienna, Austria.
  • Lisa Schwartz Foundation for Truth in Medicine, Norwich, Vermont.
  • Generation Patient, Indianapolis, Indiana.
  • Department of Advertising, Public Relations and Media Design, University of Colorado Boulder, Boulder.
  • Dartmouth Biomedical & Health Sciences Libraries, Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire.

Zitieren

APA

Gell, S., Dave, S., Willis, E., Vitale, E. J., Woloshin, S., & Heiss, R. (2026). Prescription Drug Promotion by Social Media Influencers. JAMA Network Open, 9(3), e262738. https://doi.org/10.1001/jamanetworkopen.2026.2738

Vancouver

Gell S, Dave S, Willis E, Vitale EJ, Woloshin S, Heiss R. Prescription Drug Promotion by Social Media Influencers. JAMA Network Open. 2026;9(3):e262738. doi:10.1001/jamanetworkopen.2026.2738

BibTeX
@article{Gell2026,
  author = {Gell, Sascha and Dave, Sneha and Willis, Erin and Vitale, Elaina J and Woloshin, Steven and Heiss, Raffael},
  title = {Prescription Drug Promotion by Social Media Influencers},
  journal = {JAMA Network Open},
  year = {2026},
  volume = {9},
  number = {3},
  pages = {e262738},
  doi = {10.1001/jamanetworkopen.2026.2738}
}
Kostenlos starten →